跳至主要内容
临床试验/NCT00334997
NCT00334997已完成2 期

Early Stage Glottic Cancer: Endoscopic Excision or Radiotherapy [EaStER]

University College London Hospitals12 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2005年9月1日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
50
试验地点
12
主要终点
Feasibility

研究概览

简要总结

RATIONALE: Endoscopic surgery is a less invasive type of surgery for laryngeal cancer and may have fewer side effects and improve recovery. Radiation therapy uses high-energy x-rays to kill tumor cells. It is not yet known whether endoscopic surgery is more effective than radiation therapy in treating laryngeal cancer of the glottis.

PURPOSE: This randomized phase II trial is studying endoscopic surgery to see how well it works compared with radiation therapy in treating patients with stage 0, stage I, or stage II laryngeal cancer of the glottis.

详细描述

OBJECTIVES:

  • Determine the feasibility of conducting a large phase III randomized study in the future, comparing radiotherapy vs endoscopic excision in patients with stage 0-II laryngeal cancer of the glottis.
  • Determine patient acceptability of the proposed trial design.
  • Compare the effect of using dedicated head and neck research nurses vs general nurses on patient recruitment.
  • Refine outcome measures, including voice analysis and quality of life.

OUTLINE: This is a randomized, controlled, multicenter, pilot study. Patients are stratified according to participating center and T stage (Tis or T1 vs T2a). Patients are randomized to 1 of 2 treatment arms.

  • Arm I: Patients undergo endoscopic excision via CO_2 laser or cold steel.
  • Arm II: Patients undergo radiotherapy once daily, 5 days a week, for 3-4 weeks. Patients undergo vocal analysis at baseline and at 6 months and 1 and 2 years after randomization.

Quality of life is assessed at baseline, at 1 year, and then annually for 5 years.

研究设计

研究类型
Interventional
分配方式
Randomized
主要目的
Treatment

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • DISEASE CHARACTERISTICS:
  • Histologically confirmed squamous cell carcinoma of the glottic larynx, including tumors at the anterior commissure
  • Stage 0-II (Tis, T1, or T2a)
  • No clinical or radiological sign of nodal involvement
  • No evidence of distant metastases
  • Airway anatomy suitable for endoscopic excision
  • PATIENT CHARACTERISTICS:
  • Fit to receive radical treatment as either radiotherapy or endoscopic excision
  • Life expectancy ≥ 2 years
  • No other cancer in the past 10 years except basal cell carcinoma of the skin or adequately treated carcinoma in situ of the uterine cervix
  • No vasculitic conditions adversely affecting radiotherapy
  • No other co-existing medical condition that would limit life expectancy
  • Not pregnant
  • PRIOR CONCURRENT THERAPY:
  • No concurrent chemotherapy
  • No concurrent palliative treatment

排除标准

  • 未提供

结局指标

主要结局

Feasibility

Patient acceptability

次要结局

  • Quality of life
  • Economic assessment
  • Voice analysis

研究者

发起方
University College London Hospitals
申办方类型
Other

研究点 (12)

Loading locations...

相似试验